Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 161 shares at $165.41 ($27K) on 2019-05-15, disclosed to the SEC on 2019-05-17.
Scheduled sale ($27k) by SVP & Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |